The second international Life Sciences Baltics 2014 forum to be held in Vilnius on September 10-12 will be aimed at enhancing an international cooperation between business and science in the higher value-added life sciences sector. At this forum, the world-famous representatives of the sector’s academic institutions and business enterprises will share their ideas about regenerative medicine, clinical studies, commercialisation as well as investment attraction. At the forum insights and experience in the field will be shared by representatives of Pfizer, General Electric Healthcare Sciences, the Japanese Science and Technology Agency, the European Federation of Pharmaceutical Industries and Associations (EFPIA), Israel’s Weizmann Institute, and other institutions and companies of this viable sector.
Life Sciences Baltics 2014 is the biggest international biotechnology, pharmaceutical, medical devices and equipment forum in the Baltic States which brings together life sciences experts from more than 30 countries. By encouraging the exchange of ideas, partnership and progress, the event gives an opportunity for Baltic scientists and entrepreneurs to share ideas, present their achievements, and get acquainted with the latest life sciences developments. Lithuanian Prime Minister Algirdas Butkevičius, who is the official patron of Life Sciences Baltics 2014, says the forum is a great opportunity to present the potential of the Baltic life sciences sector. “The forum is a meeting place for top tier managers and scientists from sector’s leading countries – the USA, Israel, Switzerland, Japan and Germany. I am happy that the Baltic scientists and entrepreneurs engaged in the life sciences sector are valued as desirable partners in the implementation of international programmes and projects such as FP7, Horizon 2020. Lithuanians have gained a reputation as reliable providers of quality scientific research and services in the field of life sciences. This is highly important as trustworthiness is the key element of this sector, giving companies a competitive advantage” pointed out Prime Minister Algirdas Butkevičius.
This year besides already established topics for biotechnology, pharmaceutical and medical experts, focus will be put on special sessions about opportunities in Russia and CIS countries, as well as EU policies and funding opportunities for scientific activities. Life Sciences Baltics 2014 forum brings a great opportunity to discover state-of-the-art scientific infrastructure and investor-ready startups in the Baltics.
The Life Sciences Baltics 2014 (LSB 2014) forum team has released a new promotional video which reflects highlights from a vastly successful 2012 event, and brings a glimpse to the new areas of focus in the upcoming event.
For more information about the LSB 2014 visit the website: www.lsb2014.com